GENE THERAPY WITH MODIFIED p65 PROTEINS - Patent 0854921

(19)

(11)

EP 0 854 921 A1

(12)

(43)	Date of publication:
	29.07.1998 Bulletin 1998/31

(21)	Application number: 96933407.0

(22)	Date of filing: 26.09.1996

(51)

International Patent Classification (IPC):

A01K 67/ 027^{( . )}
C12N 15/ 12^{( . )}
A61K 38/ 00^{( . )}

C07K 14/ 47^{( . )}
C12N 15/ 85^{( . )}
A61K 48/ 00^{( . )}

(86)	International application number:
	PCT/EP1996/004216

(87)	International publication number:
	WO 1997/012040 (03.04.1997 Gazette 1997/15)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

26.09.1995 US 19950000433P

(71)	Applicants:
	Novartis AG 4058 Basel (CH) Novartis-Erfindungen Verwaltungsgesellschaft m.b.H. 1235 Wien (AT)

(72)	Inventors:
	ANRATHER, Josef Boston, MA 02210 (US) BACH, Fritz B. Manchester by the Sea, MA (US) WINKLER, Hans Brookline, MA 02146 (US)

(74)	Representative: Becker, Konrad, et al
	Novartis AG Patent- und Markenabteilung CH Lichtstrasse 35 4002 Basel 4002 Basel (CH)

(54)	GENE THERAPY WITH MODIFIED p65 PROTEINS